Comparison of existing disease activity indices in the follow-up of patients with Behçet’s disease

@article{Shahram2009ComparisonOE,
  title={Comparison of existing disease activity indices in the follow-up of patients with Behçet’s disease},
  author={Farhad Shahram and Alireza Khabbazi and Abdolhadi Nadji and Naghmeh Ziaie and Arash Tehrani Banihashemi and Fereydoun Davatchi},
  journal={Modern Rheumatology},
  year={2009},
  volume={19},
  pages={536-541}
}
The objective of this study was to determine the concordance between the Iranian Behçet’s disease dynamic activity measure (IBDDAM) or the Behçet’s disease current activity form (BDCAF) and expert physician global assessment (PGA) in the evaluation of disease activity changes in Behçet’s disease (BD). In a prospective study, 117 consecutive patients with BD were evaluated in their two consecutive follow-up visits by IBDDAM and BDCAF. The change in disease activity was determined (increased… 
Is there a relation between clinical disease activity and acute phase response in Behcet's disease?
TLDR
The presence of a newly‐developed erythema nodosum, superficial thrombophlebitis, or joint involvement may be associated with higher levels of ESR and CRP, which may contribute to the overall disease activity perception in Behcet's Disease.
Development and validation of an electronic medical record-based disease activity index for Behçet's disease.
TLDR
The EMRAI, an EMR-based simplified activity index of Behçet's disease, facilitates rapid and simple gathering of disease activity data and clinical information.
Correlation of clinical signs and symptoms of Behçet’s disease with mean platelet volume (MPV) and red cell distribution width (RDW)
TLDR
BD was found to be associated with an increase in MPV and RDW, particularly during active phases, andRDW and MPV were also found to have predictive value for screening to detect BD activity and its ocular complications.
A new Mucocutaneous Activity Index for Behçet's disease.
TLDR
The mucocutaneous activity index may help decision-making process for treatment strategies in BD patients and may help decide the best way to treat patients with Beh-çet's disease.
Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease
TLDR
Serum levels of calprotectin, IMA and hsCRP in patients with BD were higher than those of the healthy control group and could be a candidate biomarker which plays a role in BD pathogenesis.
Disease Assessment in Behçet’s Disease
TLDR
Behcet’s disease starts early and may last a long time so that the whole of the working life and the family can be compromised by the disease process, and this is not widely appreciated.
Long-term outcome and predictors of remission in Behçet’s disease in daily practice
TLDR
Adherence to treatment, remission induction during the 2 years after the diagnosis and treatment for at least 6 years have significant role and achieving remission in Behcet's disease is not inaccessible.
Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review
TLDR
A systematic literature review will identify domains and candidate instruments for use in a Delphi exercise, the next step in the development of a core set of outcome measures that are properly validated and widely accepted by the collaboration of researchers from many different regions of the world.
Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease
TLDR
It is demonstrated that IL-33 and sST2 are highly expressed in patients with Behcet's disease and that serum s ST2 is an independent factor associated with IBDDAM and BDCAF, suggesting a potential role for sST 2 as a surrogate marker of disease activity in patientswith BD.
...
...

References

SHOWING 1-10 OF 17 REFERENCES
Behçet's disease: evaluation of a new instrument to measure clinical activity.
TLDR
Overall, this instrument has good interobserver reliability for assessing general disease activity in Behçet's disease and has a place in routine clinical monitoring of patients with BD, as well as assessing outcome in therapeutic trials.
A review on disease activity scores in Behçet's disease (BD)
  • M. Baltaci
  • Medicine
    Arthritis Research & Therapy
  • 2003
TLDR
The Behcet's Disease Current Activity Form (BDCAF) was developed, which depends on accurate history of clinical features present during the month prior to the date of assessment, and is a reliable method of assessing and documenting clinical activity in BD patients for use in routine clinical practice.
The Behcet's disease activity index.
TLDR
The pooled data confirmed that the index is not suitable for comparison between countries or for pooling of data in the raw form, but after fitting the data to the Rasch model such comparisons can be made.
The Behçet's disease activity index.
TLDR
The pooled data confirmed that the index is not suitable for comparison between countries or for pooling of data in the raw form, but after fitting the data to the Rasch model such comparisons can be made.
Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome.
TLDR
The results suggest that the Turkish version of BDCAF may be useful for assessing the classic triad of BS (oro-genital ulceration and eye involvement), but more experience is needed for its other parts.
Behçet's Disease
TLDR
In a prospective study of 150 patients with Behcet's disease, significant associations were shown between CRP positivity and the presence of erythema nodosum and acute thrombophlebitis, but mucocutaneous, ocular, or central nervous system activities did not show significant associations with these indices of inflammation.
Basic and Clinical Aspects
TLDR
Lesion studies in rodents provided the initial evidence that the SCN are the site of a circadian pacemaker, and in vivo and in vitro studies have since shown day-night rhythms in electric activity, metabolic activity, and gene expre~sion.
Behet's disease
...
...